Home » Funding & investments » News Digest #206 – Senti Bio Raises $53M, Inscripta $55.5M, Perfect Day $24.7M, Prokarium $10M, Boost Biomes $2M

News Digest #206 – Senti Bio Raises $53M, Inscripta $55.5M, Perfect Day $24.7M, Prokarium $10M, Boost Biomes $2M


Hi all,

Founded by pioneers in the field of synthetic biology from MIT, the Wyss Institute at Harvard, MD Anderson, Boston University, ETH Zurich, and other institutions, this week Senti Biosciences raised a $53 million Series A round to design synthetic gene circuits for adaptive cell and gene therapies.

“Senti is a start-up company focused on using synthetic biology tools to build next-generation cell and gene therapies that can adapt, sense, respond, and have a greater range of effects than current cell and gene therapies are capable of,” said Dr. Tim Lu, co-founder and CEO of Senti Biosciences.

Inscripta has closed a $55.5 million Series C funding round to accelerate commercialization of gene-editing tools — including enzymes, reagents, instrumentation, and software. Perfect Day raised a $24.7 million Series A round and received its first patent for the use of animal-free dairy proteins in food applications.

Boost Biomes launched with a $2.05 million seed round to develop microbiome-based products with a focus on sustainable food production and agriculture. In the UK, Prokarium raised $10 million to develop vaccines using a synthetic biology platform that enables thermostable microbes to be taken orally.

In other news, Riffyn was awarded its first US patent for experiment design and data analytics in biotech and pharmaceutical R&D. “Global pharma, biotech and chemical enterprises are under tremendous pressure to shorten product development cycles to address product obsolescence, pricing pressures, and realize first-to-market advantages,” noted Dr. Timothy Gardner, Riffyn’s Founder/CEO.

Source: Riffyn

Riffyn, Inscripta and Prokarium will all be speaking at SynBioBeta 2018, register by March 31st to get a discount.

Enjoy the rest of your week.

Here There (Will) Be Dragons: Beyond the Map of Synbio with Kim de Mora

It’s almost safe to say that if at any point in your scientific career you’ve been involved with synthetic biology, then you have been impacted by Kim de Mora’s work.

Kite and Sangamo to Develop Engineered Cell Therapies for Cancer

“The emergence of gene editing as a tool to edit immune cells holds promise in the development of therapies with potentially improved safety, efficacy and efficiency.”

Cargill, Precision BioSciences team up to develop canola oil using genome editing

Together, the partners are using Precision’s ARCUS® genome-editing technology to further reduce saturated fat in canola oil.

BrisSynBio Connect 12th April 2018 – Tickets Now Available!

BrisSynBio Connect finalises the 4-Day MBA programme. This free event is an opportunity to view synthetic biology entrepreneurs’ pitch their business ideas.

IndieBio’s Class Six Presents Next-Gen Therapies — Event Recap

Our writer Rodalyn Guinto attended the IndieBio event to learn more about the four stars of the night — Nivean Therapeutics, Neurocarrus, MezoMax, and Onconetics.

ATUM and Just Biotherapeutics Team Up to Accelerate Drug Discovery

ATUM licenses Leap-In Transposase® Technology to Just to rapidly catalyze the stable integration of genes into a target genome.

Who’s Hiring?

Assembly Scientist – DNA Script: Paris, France

Enzyme Production Leader – DNA Script: Paris, France

Technology Application Scientist – DNA Script: Paris, France

To feature your job here, please get in touch

All the News

Maxygen Relaunches in Sunnyvale to Offer Well-established Molecular Breeding Technology with New Collaborative Vision (Press Release)

A Biohacker Regrets Publicly Injecting Himself With CRISPR (The Atlantic)

Dyadic International and Mitsubishi Tanabe Pharma Corporation To Produce Two Target Proteins in C1 (Press Release)

Using Multiple Cell Lines to Manufacture Biotech Products (GEN)

New report from the OpenPlant IP Working Group: Towards an Open Material Transfer Agreement

Molecular Devices launches the ImageXpress® Pico Automated Cell Imaging System (Press Release)

Two Issued U.S. Patents Granted to Cellectis for CRISPR Use in T-Cells (Press Release)

Benson Hill Biosystems Receives Patent for Novel CRISPR Technology to Drive Crop Improvement (Press Release)

A New Hub for Cutting-Edge Technologies in Mission Bay: Gladstone launches the new Institute of Data Science and Biotechnology (Press Release)

TechAccel Initiates Protein Engineering Project with UC Davis to Improve Wheat Yield (Press Release)

DOE grants $10.6 million to produce more biodiesel, biojet fuel (Eureka Alert)

DEINOVE announces the first industrial batch of its innovative carotenoid (Press Release)

Copyright © %%current_year_YYYY%%, All rights reserved.

1547 Palos Verdes Mall, #411
Walnut Creek, CA 94597

About Us | Update Preferences | Unsubscribe | View email in your browser

Click here to join our weekly newsletter. We want to hear what you think about this article. Got a tip for our news team? Write to editorial@synbiobeta.com.

Editor’s picks